Latest in Ai Solve Worst

Sort by

2,667 items

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...
MarketWatch - Jan. 8
Samsung’s revival still hangs on winning Nvidia’s AI custom

South Korean group is one of only a few chipmakers with the ability to produce memory chips essential for AI applications
Financial Times - Jan. 8

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact